BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 31339744)

  • 1. Probable Galactorrhea Associated with Sequential Trials of Escitalopram and Duloxetine in an Adolescent Female.
    McGrane IR; Morefield CM; Aytes KL
    J Child Adolesc Psychopharmacol; 2019 Dec; 29(10):788-789. PubMed ID: 31339744
    [No Abstract]   [Full Text] [Related]  

  • 2. Duloxetine versus escitalopram and placebo in the treatment of patients with major depressive disorder: onset of antidepressant action, a non-inferiority study.
    Nierenberg AA; Greist JH; Mallinckrodt CH; Prakash A; Sambunaris A; Tollefson GD; Wohlreich MM
    Curr Med Res Opin; 2007 Feb; 23(2):401-16. PubMed ID: 17288694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Escitalopram versus serotonin noradrenaline reuptake inhibitors as second step treatment for patients with major depressive disorder: a pooled analysis.
    Lam RW; Lönn SL; Despiégel N
    Int Clin Psychopharmacol; 2010 Jul; 25(4):199-203. PubMed ID: 20357664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New generation antidepressants for depression in children and adolescents: a network meta-analysis.
    Hetrick SE; McKenzie JE; Bailey AP; Sharma V; Moller CI; Badcock PB; Cox GR; Merry SN; Meader N
    Cochrane Database Syst Rev; 2021 May; 5(5):CD013674. PubMed ID: 34029378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The development of new antidepressants: focus on duloxetine and escitalopram.
    Huffman JC; Perlis RH
    Harv Rev Psychiatry; 2003; 11(1):30-6. PubMed ID: 12866739
    [No Abstract]   [Full Text] [Related]  

  • 6. The treatment of SSRI-resistant depression in adolescents (TORDIA): in search of the best next step.
    Brent DA
    Depress Anxiety; 2009; 26(10):871-4. PubMed ID: 19798756
    [No Abstract]   [Full Text] [Related]  

  • 7. Recurrent hyponatremia after substitution of citalopram with duloxetine.
    Dirks AC; van Hyfte DM
    J Clin Psychopharmacol; 2007 Jun; 27(3):313. PubMed ID: 17502788
    [No Abstract]   [Full Text] [Related]  

  • 8. Vortioxetine for major depressive disorder: An indirect comparison with duloxetine, escitalopram, levomilnacipran, sertraline, venlafaxine, and vilazodone, using number needed to treat, number needed to harm, and likelihood to be helped or harmed.
    Citrome L
    J Affect Disord; 2016 May; 196():225-33. PubMed ID: 26938965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Escitalopram and duloxetine in the treatment of major depressive disorder: a pooled analysis of two trials.
    Lam RW; Andersen HF; Wade AG
    Int Clin Psychopharmacol; 2008 Jul; 23(4):181-7. PubMed ID: 18545055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in sexual functioning associated with duloxetine, escitalopram, and placebo in the treatment of patients with major depressive disorder.
    Clayton A; Kornstein S; Prakash A; Mallinckrodt C; Wohlreich M
    J Sex Med; 2007 Jul; 4(4 Pt 1):917-29. PubMed ID: 17627739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-blind comparison of escitalopram and duloxetine in the acute treatment of major depressive disorder.
    Khan A; Bose A; Alexopoulos GS; Gommoll C; Li D; Gandhi C
    Clin Drug Investig; 2007; 27(7):481-92. PubMed ID: 17563128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Digging for data on harms in duloxetine trials.
    Doshi P; Zito J; dosReis S
    BMJ; 2014 Jun; 348():g3578. PubMed ID: 24904123
    [No Abstract]   [Full Text] [Related]  

  • 13. Newer antidepressants: review of efficacy and safety of escitalopram and duloxetine.
    Hirschfeld RM; Vornik LA
    J Clin Psychiatry; 2004; 65 Suppl 4():46-52. PubMed ID: 15046541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case with euprolactinemic galactorrhea induced by escitalopram.
    Gulsun M; Algul A; Semiz UB; Ates MA; Doruk A; Ebrinc S; Basoglu C; Cetin M
    Int J Psychiatry Med; 2007; 37(3):275-8. PubMed ID: 18314855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective Serotonin Reuptake Inhibitor Use and Risk of Arrhythmia: A Nationwide, Population-Based Cohort Study.
    Lin YT; Lu TS; Hansen RA; Wang CC
    Clin Ther; 2019 Jun; 41(6):1128-1138.e8. PubMed ID: 31178037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Galactorrhoea and the use of selective serotonin reuptake inhibitors].
    Wessels-van Middendorp AM; Timmerman L
    Tijdschr Psychiatr; 2006; 48(3):229-34. PubMed ID: 16956087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does the new antidepressant duloxetine (Cymbalta) have any advantages over other antidepressant drugs?
    Miller MC
    Harv Ment Health Lett; 2004 Nov; 21(5):8. PubMed ID: 15556908
    [No Abstract]   [Full Text] [Related]  

  • 18. Neonatal morbidity due to maternal use of two antidepressant drugs.
    Jwa S; Wada Y; Yamamoto M; Sumida Y
    Pediatr Int; 2018 Jan; 60(1):87-88. PubMed ID: 29235219
    [No Abstract]   [Full Text] [Related]  

  • 19. Hyponatremia Due to Escitalopram and Thiazide Use After Cardiac Surgery.
    Diken Aİ; Yalçınkaya A; Erçen Diken Ö; Aksoy E; Doğan İ; Yılmaz S; Çağlı K
    J Card Surg; 2016 Feb; 31(2):96-7. PubMed ID: 26687322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, double-blind, duloxetine-referenced study comparing efficacy and tolerability of 2 fixed doses of vortioxetine in the acute treatment of adults with MDD.
    Mahableshwarkar AR; Jacobsen PL; Chen Y; Serenko M; Trivedi MH
    Psychopharmacology (Berl); 2015 Jun; 232(12):2061-70. PubMed ID: 25575488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.